about
The stomach in health and diseaseInterleukin-1 polymorphisms associated with increased risk of gastric cancerFusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentNot All Mice Are the Same: Standardization of Animal Research Data Presentation.Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura.The inflammatory microenvironment in colorectal neoplasia.Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities?Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis.Detection of Campylobacter concisus and other Campylobacter species in colonic biopsies from adults with ulcerative colitisCellular and molecular aspects of gastric cancer.A comprehensive evaluation of colonic mucosal isolates of Sutterella wadsworthensis from inflammatory bowel disease.Cancer and inflammation: promise for biologic therapy.IBD-what role do Proteobacteria play?Programmed chemotherapy for patients with metastatic unresectable gastric cancer.Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study.A study of the pathogenesis of Helicobacter pylori negative chronic duodenal ulcerationLow prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazineInterobserver reliability in the endoscopic diagnosis and grading of Barrett's esophagus: an Asian multinational study.Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer.Porphyrin metabolism and haem biosynthesis in Gilbert's syndrome.Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals.Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.How does H. pylori infection cause gastric cancer?The fungal microbiota of de-novo paediatric inflammatory bowel disease.Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland.Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy.Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy.Sporadic colorectal cancer--role of the commensal microbiota.Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations.GP management of dyspepsia.Iron deficiency and Helicobacter pylori-induced gastric cancer: too little, too bad.Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.Role of host genes in sporadic gastric cancer.The interaction of host genetic factors and Helicobacter pylori infection.Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
P50
Q26784036-A4798180-3119-40C4-975E-FC8DE9F98374Q28140456-698E1189-8209-43D8-8CAD-A61FDFE033D5Q28296759-108A4F9C-10A0-4BAC-8BC6-5FBA6102A716Q31097380-D56B3AD4-D16A-4E2A-B25A-B69C0AE15D2CQ33362559-B5501EA3-2F8A-41DF-8B69-4D03C7269214Q33797695-8B872C22-4F3D-4C36-8F1E-C4F8CCFBC020Q33839318-8D6A57C0-F5EA-4976-BAA3-397AD4A06A7BQ33858740-32D0DB31-52F1-4F7C-95B5-E5872AB07BBCQ33954947-1B49E17C-A64C-4370-BDD3-7D18B0F98DF8Q34012910-7ABA8A2D-EB82-4D10-91C1-CFC653922281Q34071463-17E2665F-5815-478A-AFF9-0FADFFB9A87BQ34139732-57452191-7598-4D49-8C17-4B4C0FFF33EFQ34255700-5BD92EC2-857B-437C-9744-C47CB2F05613Q34325743-2E95E8FE-AF07-4E62-99B1-1E90A7A3710BQ34348466-8A122411-9EB2-4951-AD14-1E17F3A9B498Q34376963-EA37AE19-273B-41FD-9821-789E2CE98BC1Q34379741-741E86DC-CCFD-45C2-85FB-8A1ED5532CBCQ34396755-A0B1E764-5FAA-4659-96DD-EFD295CEDF64Q34407175-1A5D25AA-D50D-44AE-89FD-95FAF7548D45Q34445270-A7C08CAA-3661-43C3-9043-5D804DFFC15AQ34485643-006E9213-188D-4B8B-B350-B7E3778F951CQ34527857-A25DAFD9-E947-4979-87BE-9B3B20DDFD14Q34542021-18ED52D1-3D25-429A-B017-2813B7A2688BQ34543335-859CC03D-5B86-499F-8E09-ECD2F7FE7A92Q34554247-9EFA11DA-DB1F-4AD2-989C-73BB0BAB9D48Q34648376-774B1487-56C4-4469-88BA-0B084F474009Q35045731-72BFA864-5720-447D-A3A3-DB4A4E1A77CEQ35529988-4CB0DFF4-39FB-428B-83D4-0E6BF180C88DQ35542920-9337F5EC-DBEA-4A1A-9D14-4C3CAC49EE71Q35686407-2B9D7D24-AE3E-4C5A-B781-D4E558186E5CQ35760994-754FFADF-259E-4AB1-B36D-7E561C8FDDF5Q36053072-0466A394-14AD-4155-8CCB-6C71E09834ACQ36284993-A34C2C2B-2E84-4290-9B56-646FC27DA0ABQ36433813-25FFC8D3-0A73-4F74-AC59-BE52DAD28871Q36497304-93417366-652E-4B5F-921D-617FC6263F17Q36530028-C3FA44BA-AA1F-452C-83DD-305068D50907Q36601944-059EDBF2-A479-4252-9E1D-52B62B816787Q36745510-08ED17D6-1F35-45C6-B5D4-9A8DC55E2DA8Q36861172-1053AE16-D638-49B5-8398-27F5A834F8D5Q36959156-C8EFE84A-0425-4E5B-913A-A6C1777ECE02
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emad M El-Omar
@ast
Emad M El-Omar
@en
Emad M El-Omar
@es
Emad M El-Omar
@nl
Emad M El-Omar
@sl
type
label
Emad M El-Omar
@ast
Emad M El-Omar
@en
Emad M El-Omar
@es
Emad M El-Omar
@nl
Emad M El-Omar
@sl
prefLabel
Emad M El-Omar
@ast
Emad M El-Omar
@en
Emad M El-Omar
@es
Emad M El-Omar
@nl
Emad M El-Omar
@sl
P108
P106
P31
P496
0000-0002-0011-3924